Health & Fitness NIH awards $470 million to study the effects of long Covid
8 benefits of yoga
Wondering what the benefits of yoga are? Read on to discover the answers.Whether you’re looking to buy a yoga mat and try an online class or you’re thinking of venturing out to a studio class, we’ll be looking at eight benefits of yoga for the body and mind.
The National Institutes of Health (NIH) hasto researchers who will study the long-term impacts of among thousands of patients.
This grant will go to New York University (NYU) Langone Medical Center, which will act as the central hub for long Covid research and provide smaller grants to more than 100 scientists.
The $470 million represents about 40 percent of $1.15 billion that Congress allocated for long Covid research in the American Rescue Plan.
NIH director Dr Francis Collins says the award is a major step for tens of thousands of long Covid patients in the U.S., many of whom 'have had their lives completely upended by the major long-term effects of COVID-19.'
Aloe Vera Benefits: 16 Health and Beauty Uses for the Super Succulent
Aloe, aloe, aloe.
In February 2021, the NIH announced a new initiative to study long Covid, the condition in which patients have prolonged symptoms for weeks or months after their coronavirus infection.
Theseneurological issues like fatigue and brain fog, shortness of breath, chronic cough, anxiety and depression, gastrointestinal issues, and many others.
Weird gadget may cure hiccups, early study suggests
A new study hints that the device works, but more studies are needed to rule out a placebo effect.When a bout of hiccups strikes, the brain stem shoots signals to the diaphragm that cause the muscle to contract and pull a gulp of air into the lungs; then the epiglottis, a flap of tissue behind the tongue, flips over to cover the windpipe and triggers the characteristic "hic" sound that give hiccups their name, Live Science previously reported. The involuntary reflex may serve some purpose in fetuses and newborns, in that hiccups may help train the brain regions and muscles involved in breath control.
According to NIH estimates, between 10 and 30 percent of people infected with the coronavirus will experience long-term symptoms.
Some long Covid patients who originally contracted the virus in spring 2020 are still experiencing symptoms.
The condition, recent studies have shown - though the risk of long Covid is much lower for vaccinated people who experience a breakthrough case.
The NIH effort to study this condition - called the RECOVER Initiative - has received $1.15 billion in funding over four years from Congress, via the American Rescue Plan.
After months of limited news about the RECOVER Initiative, the NIH announced on Wednesday that it's awarded nearly $470 million in a research grant to study long Covid.
'We know some people have had their lives completely upended by the major long-term effects of COVID-19,' said Collins.
2 scientists win $3 million 'Breakthrough Prize' for mRNA tech behind COVID-19 vaccines
Two scientists who developed a technology used in COVID-19 mRNA vaccines have been awarded a $3 million prize. © Provided by Live Science Images of Katalin Karikó (left) and Drew Weissman (right) Now in their 10th year, the Breakthrough Prizes recognize leading researchers in the fields of fundamental physics, life sciences and mathematics. Each prize comes with a $3 million award, supplied by the foundation's founding sponsors Sergey Brin, Priscilla Chan and Mark Zuckerberg, Yuri and Julia Milner, and Anne Wojcicki.
'These studies will aim to determine the cause and find much needed answers to prevent this often-debilitating condition and help those who suffer move toward recovery.'
The hefty award went to NYU Langone Medical Center, which will award smaller grants from that $470 million to over 100 researchers at over 30 institutions, the NIH announced.
These institutions intend to leverage existing long Covid research efforts and recruit new patients into study group encompassing tens of thousands.
Scientists plan to collect a wealth of data on the RECOVER Cohort. This includes clinical information, lab tests, and analysis of patients' stages of recovery.
'This scientifically rigorous approach puts into place a collaborative and multidisciplinary research community inclusive of diverse research participants that are critical to informing the treatment and prevention of the long-term effects of COVID-19,' said Dr Gary Gibbons, one of the co-chairs of the RECOVER Initiative.
Covid? What Covid? Moderna boss expects pandemic to be done in a year
Moderna's chief executive Stéphane Bancel said there will be enough jabs to vaccinate the world's 8billion people by the middle of next year and he expects a return to normal by this time in 2022.Moderna's chief executive Stéphane Bancel said enough jabs will have been made to vaccinate all of the world's 7.7billion people by the middle of next year.
In developing the RECOVER Initiative's protocols, the NIH worked with researchers who have already been studying long COVID as well as patients themselves.
Patient groups likehave advocated for scientists to include diverse groups of long Covid patients in their research - including those who were not hospitalized or didn't obtain a positive test result.
Many long Covid patients who were infected early in the pandemic were unable to get tested due to limited testing supplies and other access issues, excluding them from some later studies.
The RECOVER Initiative intends to include a diverse group of adults, children, pregnant people, and patients in different stages of their Covid infections.
Patients who would like to volunteer for the initiative can sign up at an NIH website,.
The NIH initiative also aims to standardize clinical trial designs, ensuring that researchers at different institutions analyze data in the same way.
Researchers will use electronic health records as well as mobile health tech, such as smartphone apps and wearable devices, to track patients.
Through the initiative, NIH scientists aim to determine what exactly causes long Covid - a question that has yet to be definitively answered.
MS drug does NOT improve condition of hospitalized COVID-19 patients
A clinical trial from the NIH found that there was no difference in the time of recovery when hospitalized Covid patients were given interferon beta-1a compared to just remdesivir.The National Institutes of Health (NIH) released results from a clinical trial on Monday looking at the drug, called interferon beta-1a, as a treatment for the virus.
'Is it a misfiring of the immune system that fails to reset after the infection with this coronavirus? Is it a triggering of some metabolic dysfunction? We don't know,' Collinson Wednesday.
'The diversity of symptoms and presentations leads us to believe that long Covid is not just one condition.
'The only way, therefore, we're going to sort this out is with very large studies that collect lots and lots of data about symptoms, physical findings and laboratory measures.'
NIH scientists also intend to better understand the range of long Covid symptoms, risk factors for the condition, and possible treatments.
'Given the range of symptoms that have been reported, intensive research using all available tools is necessary to understand what happens to stall recovery from this terrible virus,' said Dr Walter Koroshetz, also a RECOVER co-chair.
The NIH also recently awarded smaller long Covid research grants to the NYU Grossman School of Medicine and the Biostatistics Center at Massachusetts General Hospital.
Pfizer vaccine side effects: Eight 'very common' side effects of the Pfizer Covid vaccine .
PFIZER vaccines have been handed out to millions of people in the UK as an alternative to the AstraZeneca and Moderna jabs. But what are the Pfizer vaccine side effects? These are the eight "very common" side effects of the Covid vaccine you should watch out for, including headaches and tiredness.The Pfizer/BioNTech Covid vaccine is a type of active immunisation against COVID-19.